BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16709475)

  • 1. Hyperlipidemia in children.
    McCrindle BW
    Thromb Res; 2006; 118(1):49-58. PubMed ID: 16709475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol screening in school children: is family history reliable to choose the ones to screen?
    Derinoz O; Tumer L; Hasanoglu A; Pasaoglu H; Aksakal FN; Ceyhan MN
    Acta Paediatr; 2007 Dec; 96(12):1794-8. PubMed ID: 17971187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition evidence-based guidelines for treating hyperlipidemia in children with type 1 diabetes: a case presentation.
    Robinson MT
    Diabetes Educ; 2009; 35(3):408-19. PubMed ID: 19349468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid management in children.
    Zappalla FR; Gidding SS
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):171-83. PubMed ID: 19217518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and management of hyperlipidemia in children and young adults.
    Kafonek SD; Kwiterovich PO
    Compr Ther; 1989 Apr; 15(4):54-62. PubMed ID: 2650983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening adolescents for lipid disorders: what is the best approach?
    Jenssen BP; Jacobson MS
    Adolesc Med State Art Rev; 2008 Dec; 19(3):507-20, x. PubMed ID: 19227389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?
    Glaser NS; Geller DH; Haqq A; Gitelman S; Malloy M;
    Pediatr Diabetes; 2011 Jun; 12(4 Pt 2):442-59. PubMed ID: 21054719
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis prevention and treatment in children and adolescents.
    Oliveira FL; Patin RV; Escrivão MA
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):513-28. PubMed ID: 20397826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia in adolescents.
    Kanani PM; Sperling MA
    Adolesc Med; 2002 Feb; 13(1):37-52, v-vi. PubMed ID: 11841954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.
    Kapur NK
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):161-75. PubMed ID: 17338662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. School children have leading risk factors for cardiovascular disease and diabetes: the Wausau SCHOOL project.
    Hughes P; Murdock DK; Olson K; Juza R; Jenkins K; Wegner A; Hendricks B
    WMJ; 2006 Jul; 105(5):32-9. PubMed ID: 16933411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult atherosclerosis and physical vascular examination: a simple strategy to avoid inadequate cardiovascular prevention and under-use of diagnostic vascular guidelines in outpatients. A multicenter study by Angiology Care Units in North-Eastern Italy.
    Marzolo M; Verlato F; Zotta L; Guadagnin ML; Borgese L; Cravatari M; Nardi M; Camporese G; Andreozzi GM
    Int Angiol; 2008 Oct; 27(5):426-32. PubMed ID: 18974707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidemia: a preliminary report.
    Gheith O; Sheashaa H; Abdelsalam M; Shoeir Z; Sobh M
    Eur J Intern Med; 2009 May; 20(3):e57-61. PubMed ID: 19393480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.